Heparin and Disseminated intravascular coagulation - a phase IV clinical study of FDA data

Summary:

Disseminated intravascular coagulation is reported as a side effect among people who take Heparin (heparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have High blood pressure.

The phase IV clinical study analyzes which people have Disseminated intravascular coagulation when taking Heparin. It is created by eHealthMe based on reports of 91,860 people who have side effects when taking Heparin from the FDA, and is updated regularly.

What is Heparin?

Heparin has active ingredients of heparin sodium. It is often used in blood clots. eHealthMe is studying from 92,141 Heparin users. Check the latest studies of Heparin.

What is Disseminated intravascular coagulation?

Disseminated intravascular coagulation (systemic activation of blood coagulation) is found to be associated with 1,168 drugs and 1,771 conditions by eHealthMe. Check the latest studies of Disseminated intravascular coagulation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

91,860 people reported to have side effects when taking Heparin.
Among them, 818 people (0.89%) have Disseminated intravascular coagulation.

Could Heparin cause Disseminated intravascular coagulation?

Among these 818 people:

How long have people been on Heparin when they have Disseminated intravascular coagulation? *

What is the gender of people who have Disseminated intravascular coagulation when taking Heparin? *

Click here to view

What is the age of people who have Disseminated intravascular coagulation when taking Heparin? *

What are other drugs people take besides Heparin? *

Click here to view

What are other side effects people have besides Disseminated intravascular coagulation? *

Click here to view

What are the existing conditions these people have? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Heparin and have Disseminated intravascular coagulation?

- Check whether Disseminated intravascular coagulation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Heparin:

Disseminated intravascular coagulation treatments and more:

How severe was Disseminated intravascular coagulation and when was it recovered:

Expand to all the drugs that have ingredients of heparin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Heparin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disseminated intravascular coagulation:

Browse all the conditions that are associated with Disseminated intravascular coagulation:


How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Heparin) and Heparin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: